世界の中枢神経系（CNS）覚醒剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Central Nervous System (CNS) Stimulant Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5650
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、中枢神経系（CNS）覚醒剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（注意欠陥多動性障害、ナルコレプシー、その他）、用途別市場規模（病院、研究所、研究機関、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・中枢神経系（CNS）覚醒剤の市場動向
・企業の競争状況、市場シェア
・中枢神経系（CNS）覚醒剤の種類別市場規模と予測2016-2027（注意欠陥多動性障害、ナルコレプシー、その他）
・中枢神経系（CNS）覚醒剤の用途別市場規模と予測2016-2027（病院、研究所、研究機関、診療所、その他）
・中枢神経系（CNS）覚醒剤の北米市場規模2016-2027（アメリカ、カナダ）
・中枢神経系（CNS）覚醒剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・中枢神経系（CNS）覚醒剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・中枢神経系（CNS）覚醒剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・中枢神経系（CNS）覚醒剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline Plc、Johnson & Johnson Services Inc.、Novartis AG、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.）
・結論

The central nervous system (CNS) is the part of the nervous system consisting of the brain and spinal cord.
The increasing prevalence of CNS disorders such as sleep apnea, narcolepsy, and attention-deficit hyperactivity across the world is increasing the sales and consumption of central nervous system stimulant drugs. Attention-deficit hyperactivity disorder, which is characterized by inattention, hyperactivity, and impulsivity interferes with the development and functioning of a person. Attention-deficit hyperactivity disorder is common among children and adolescents. Similarly, narcolepsy, a neurological sleep disorder, is characterized by chronic and excessive attacks of drowsiness during the day. The indication is common among children in their early childhood and older adults who are 50 years and above.

Market Analysis and Insights: Global Central Nervous System (CNS) Stimulant Drugs Market
The global Central Nervous System (CNS) Stimulant Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Central Nervous System (CNS) Stimulant Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Central Nervous System (CNS) Stimulant Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Central Nervous System (CNS) Stimulant Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Central Nervous System (CNS) Stimulant Drugs market.

Global Central Nervous System (CNS) Stimulant Drugs Scope and Market Size
Central Nervous System (CNS) Stimulant Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Central Nervous System (CNS) Stimulant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Attention-deficit Hyperactivity Disorder
Narcolepsy
Others

Segment by Application
Hospital
Research Institutes and Research Institutions
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline Plc
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Stimulant Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Attention-deficit Hyperactivity Disorder
1.2.3 Narcolepsy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Stimulant Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institutes and Research Institutions
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Stimulant Drugs Market Perspective (2016-2027)
2.2 Central Nervous System (CNS) Stimulant Drugs Growth Trends by Regions
2.2.1 Central Nervous System (CNS) Stimulant Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Central Nervous System (CNS) Stimulant Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Central Nervous System (CNS) Stimulant Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Central Nervous System (CNS) Stimulant Drugs Industry Dynamic
2.3.1 Central Nervous System (CNS) Stimulant Drugs Market Trends
2.3.2 Central Nervous System (CNS) Stimulant Drugs Market Drivers
2.3.3 Central Nervous System (CNS) Stimulant Drugs Market Challenges
2.3.4 Central Nervous System (CNS) Stimulant Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Stimulant Drugs Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Stimulant Drugs Players by Revenue (2016-2021)
3.1.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Central Nervous System (CNS) Stimulant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Central Nervous System (CNS) Stimulant Drugs Revenue
3.4 Global Central Nervous System (CNS) Stimulant Drugs Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Stimulant Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Stimulant Drugs Revenue in 2020
3.5 Central Nervous System (CNS) Stimulant Drugs Key Players Head office and Area Served
3.6 Key Players Central Nervous System (CNS) Stimulant Drugs Product Solution and Service
3.7 Date of Enter into Central Nervous System (CNS) Stimulant Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Central Nervous System (CNS) Stimulant Drugs Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Stimulant Drugs Historic Market Size by Type (2016-2021)
4.2 Global Central Nervous System (CNS) Stimulant Drugs Forecasted Market Size by Type (2022-2027)

5 Central Nervous System (CNS) Stimulant Drugs Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Stimulant Drugs Historic Market Size by Application (2016-2021)
5.2 Global Central Nervous System (CNS) Stimulant Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Central Nervous System (CNS) Stimulant Drugs Market Size (2016-2027)
6.2 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Type
6.2.1 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021)
6.2.2 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2022-2027)
6.2.3 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2027)
6.3 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Application
6.3.1 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2021)
6.3.2 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2022-2027)
6.3.3 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2027)
6.4 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Country
6.4.1 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2016-2021)
6.4.2 North America Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Central Nervous System (CNS) Stimulant Drugs Market Size (2016-2027)
7.2 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Type
7.2.1 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021)
7.2.2 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2022-2027)
7.2.3 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2027)
7.3 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Application
7.3.1 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2021)
7.3.2 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2022-2027)
7.3.3 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2027)
7.4 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Country
7.4.1 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2016-2021)
7.4.2 Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size (2016-2027)
8.2 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Type
8.2.1 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Application
8.3.1 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Region
8.4.1 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size (2016-2027)
9.2 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Type
9.2.1 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2027)
9.3 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Application
9.3.1 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2027)
9.4 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Country
9.4.1 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size (2016-2027)
10.2 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Type
10.2.1 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Application
10.3.1 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Country
10.4.1 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Company Details
11.1.2 GlaxoSmithKline Plc Business Overview
11.1.3 GlaxoSmithKline Plc Central Nervous System (CNS) Stimulant Drugs Introduction
11.1.4 GlaxoSmithKline Plc Revenue in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021)
11.1.5 GlaxoSmithKline Plc Recent Development
11.2 Johnson & Johnson Services Inc.
11.2.1 Johnson & Johnson Services Inc. Company Details
11.2.2 Johnson & Johnson Services Inc. Business Overview
11.2.3 Johnson & Johnson Services Inc. Central Nervous System (CNS) Stimulant Drugs Introduction
11.2.4 Johnson & Johnson Services Inc. Revenue in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021)
11.2.5 Johnson & Johnson Services Inc. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Central Nervous System (CNS) Stimulant Drugs Introduction
11.3.4 Novartis AG Revenue in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Central Nervous System (CNS) Stimulant Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021)
11.4.5 Pfizer Inc. Recent Development
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Details
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Central Nervous System (CNS) Stimulant Drugs Introduction
11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021)
11.5.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Central Nervous System (CNS) Stimulant Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Attention-deficit Hyperactivity Disorder
Table 3. Key Players of Narcolepsy
Table 4. Key Players of Others
Table 5. Global Central Nervous System (CNS) Stimulant Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Central Nervous System (CNS) Stimulant Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Central Nervous System (CNS) Stimulant Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Central Nervous System (CNS) Stimulant Drugs Market Share by Regions (2016-2021)
Table 9. Global Central Nervous System (CNS) Stimulant Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Central Nervous System (CNS) Stimulant Drugs Market Share by Regions (2022-2027)
Table 11. Central Nervous System (CNS) Stimulant Drugs Market Trends
Table 12. Central Nervous System (CNS) Stimulant Drugs Market Drivers
Table 13. Central Nervous System (CNS) Stimulant Drugs Market Challenges
Table 14. Central Nervous System (CNS) Stimulant Drugs Market Restraints
Table 15. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Central Nervous System (CNS) Stimulant Drugs Market Share by Players (2016-2021)
Table 17. Global Top Central Nervous System (CNS) Stimulant Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System (CNS) Stimulant Drugs as of 2020)
Table 18. Ranking of Global Top Central Nervous System (CNS) Stimulant Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Central Nervous System (CNS) Stimulant Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Central Nervous System (CNS) Stimulant Drugs Product Solution and Service
Table 22. Date of Enter into Central Nervous System (CNS) Stimulant Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Central Nervous System (CNS) Stimulant Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Central Nervous System (CNS) Stimulant Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Central Nervous System (CNS) Stimulant Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Plc Company Details
Table 63. GlaxoSmithKline Plc Business Overview
Table 64. GlaxoSmithKline Plc Central Nervous System (CNS) Stimulant Drugs Product
Table 65. GlaxoSmithKline Plc Revenue in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Plc Recent Development
Table 67. Johnson & Johnson Services Inc. Company Details
Table 68. Johnson & Johnson Services Inc. Business Overview
Table 69. Johnson & Johnson Services Inc. Central Nervous System (CNS) Stimulant Drugs Product
Table 70. Johnson & Johnson Services Inc. Revenue in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021) & (US$ Million)
Table 71. Johnson & Johnson Services Inc. Recent Development
Table 72. Novartis AG Company Details
Table 73. Novartis AG Business Overview
Table 74. Novartis AG Central Nervous System (CNS) Stimulant Drugs Product
Table 75. Novartis AG Revenue in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021) & (US$ Million)
Table 76. Novartis AG Recent Development
Table 77. Pfizer Inc. Company Details
Table 78. Pfizer Inc. Business Overview
Table 79. Pfizer Inc. Central Nervous System (CNS) Stimulant Drugs Product
Table 80. Pfizer Inc. Revenue in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021) & (US$ Million)
Table 81. Pfizer Inc. Recent Development
Table 82. Teva Pharmaceutical Industries Ltd. Company Details
Table 83. Teva Pharmaceutical Industries Ltd. Business Overview
Table 84. Teva Pharmaceutical Industries Ltd. Central Nervous System (CNS) Stimulant Drugs Product
Table 85. Teva Pharmaceutical Industries Ltd. Revenue in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021) & (US$ Million)
Table 86. Teva Pharmaceutical Industries Ltd. Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Central Nervous System (CNS) Stimulant Drugs Market Share by Type: 2020 VS 2027
Figure 2. Attention-deficit Hyperactivity Disorder Features
Figure 3. Narcolepsy Features
Figure 4. Others Features
Figure 5. Global Central Nervous System (CNS) Stimulant Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Research Institutes and Research Institutions Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Central Nervous System (CNS) Stimulant Drugs Report Years Considered
Figure 11. Global Central Nervous System (CNS) Stimulant Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Central Nervous System (CNS) Stimulant Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Central Nervous System (CNS) Stimulant Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Central Nervous System (CNS) Stimulant Drugs Market Share by Regions (2022-2027)
Figure 15. Global Central Nervous System (CNS) Stimulant Drugs Market Share by Players in 2020
Figure 16. Global Top Central Nervous System (CNS) Stimulant Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System (CNS) Stimulant Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Stimulant Drugs Revenue in 2020
Figure 18. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Central Nervous System (CNS) Stimulant Drugs Market Share by Type (2016-2027)
Figure 22. North America Central Nervous System (CNS) Stimulant Drugs Market Share by Application (2016-2027)
Figure 23. North America Central Nervous System (CNS) Stimulant Drugs Market Share by Country (2016-2027)
Figure 24. United States Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Central Nervous System (CNS) Stimulant Drugs Market Share by Type (2016-2027)
Figure 28. Europe Central Nervous System (CNS) Stimulant Drugs Market Share by Application (2016-2027)
Figure 29. Europe Central Nervous System (CNS) Stimulant Drugs Market Share by Country (2016-2027)
Figure 30. Germany Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Share by Region (2016-2027)
Figure 40. China Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Central Nervous System (CNS) Stimulant Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Central Nervous System (CNS) Stimulant Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Central Nervous System (CNS) Stimulant Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Central Nervous System (CNS) Stimulant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline Plc Revenue Growth Rate in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021)
Figure 60. Johnson & Johnson Services Inc. Revenue Growth Rate in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021)
Figure 61. Novartis AG Revenue Growth Rate in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021)
Figure 62. Pfizer Inc. Revenue Growth Rate in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021)
Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Central Nervous System (CNS) Stimulant Drugs Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の掻痒治療薬市場規模・現状・予測（2021年-2027年）

Global Pruritus Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5973 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、掻痒治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口、非経口）、用途別市場規模（血液性そう痒症、腫瘍性そう痒症、腎性そう痒症、内分泌性そう痒症、胆汁うっ滞性そう痒症）、主要地域別市場規...

世界のクリプトコックス症治療薬市場規模・現状・予測（2021年-2027年）

Global Cryptococcosis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5681 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、クリプトコックス症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アムホテリシンB、フルシトシン、フルコナゾール、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米...

世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年）

Global Beta-Lactam Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5615 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、β-ラクタム系薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペニシリン、セファロスポリン、カルバペネム、モノバクテリア）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模...

世界の心理療法薬市場規模・現状・予測（2021年-2027年）

Global Psychotherapeutic Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4784 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、心理療法薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗精神病薬、抗うつ薬、心理療法併用）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の体部白癬治療薬市場規模・現状・予測（2021年-2027年）

Global Tinea Corporis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4959 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、体部白癬治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗真菌剤、ステロイド、抗感染薬組み合わせ）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州...

世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年）

Global Viral Pneumonia Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5025 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ウイルス性肺炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リバビリン、アシクロビル、ガンシクロビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模...

世界のエリスロポエチン（EPO）薬剤市場規模・現状・予測（2021年-2027年）

Global Erythropoietin (EPO) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4206 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、エリスロポエチン（EPO）薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エポエチンアルファ、ダルベポエチンアルファ）、用途別市場規模（病院、ホームケア、専門クリニック、その他）、主要地域別市場規...

世界の免疫学的治療薬市場規模・現状・予測（2021年-2027年）

Global Immunotherapeutic Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5798 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、免疫学的治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、ワクチン、チェックポイント阻害剤、インターフェロン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米...

世界の副腎皮質がん用治療薬市場規模・現状・予測（2021年-2027年）

Global Adrenocortical Carcinoma Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5567 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、副腎皮質がん用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法）、用途別市場規模（病院、研究機関、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の全身性強皮症治療薬市場規模・現状・予測（2021年-2027年）

Global Systemic Scleroderma Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6029 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、全身性強皮症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、ホスホジエステラーゼ5阻害剤-PHA、エンドセリン受容体拮抗薬、プロスタサイクリン類似体、カルシウムチャネル遮断薬、その他...

中枢神経系疾患薬品のグローバル市場：規模・現状・予測2019-2025 A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous systemIn 2018, the global Drugs for Central Nervous System Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of x…
中枢神経系疾患薬品のグローバル市場：規模・現状・予測2019-2025 A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous systemIn 2018, the global Drugs for Central Nervous System Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of x…
世界の掻痒治療薬市場規模・現状・予測（2021年-2027年） Transdermal drug delivery systems are the most preferred methods of delivering pruritus drugs. The majority of the pruritus drugs are available in semi-solid topical dosage forms, such as lotions, gels, and creams, which are easier to apply, are less painful, and provides faster action than other fo…
注意欠陥多動性障害(ADHD)薬のグローバル市場調査 2019年 The global Attention Deficit Hyperactivity Disorder (ADHD) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Attention Deficit Hyperactivity Disorder (ADHD) Drug volume and value at global level,…
世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Beta-Lactam Drugs Market The global Beta-Lactam Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…